Otsuka Sues To Block Intas' Generic Abilify
Otsuka Pharmaceutical Co. Ltd. has sued Intas Pharmaceuticals Ltd. and its subsidiaries in New Jersey federal court for allegedly infringing its patent on the widely prescribed antipsychotic medication Abilify, after an...To view the full article, register now.
Already a subscriber? Click here to view full article